Related Experiment Videos
A small-molecule antagonist of virion assembly
1School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089, USA. neamati@usc.edu
Expert Opinion on Investigational Drugs
|January 12, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
British journal of cancer·2015
Retroviral integrase : a novel target in antiviral drug development and basic in vitro assays with the purified enzyme.
Methods in molecular medicine·2011
An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integrase.
European journal of medicinal chemistry·2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
International journal of oncology·2006
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase.
Bioorganic & medicinal chemistry·2001
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
Bioorganic & medicinal chemistry letters·2001
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.
Expert opinion on investigational drugs·2026
Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.
Expert opinion on investigational drugs·2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Expert opinion on investigational drugs·2026
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Budigalimab: a viable option for patients with advanced solid tumors.
Expert opinion on investigational drugs·2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Expert opinion on investigational drugs·2026
SafeSense: An open-access safety atlas for antisense oligonucleotides adverse events in human.
Molecular therapy. Nucleic acids·2026
A highly efficient one-pot approach for the synthesis of novel 5-amino-4-Cyano-Pyrazoles with promising anti-inflammatory and broad-spectrum antimicrobial activity.
Biochemical and biophysical research communications·2026
NiH Catalysis-Enabled Synthesis of 4-Arylpiperidines from Pyridines and Aryl Iodides.
The Journal of organic chemistry·2026